In the name of continuity is the participation of the company in the International Trade Fair of Medicine and Hospital Technology in Düsseldorf, where the entire range of devices will be exhibited, with particular focus reserved for the therapeutic solutions ‘HIRO TT’ and ‘MiS’.
2019 is a year of milestones for ASA. After having officially inaugurated the new production plant, the company reaches another important milestone: 35 years of participation in Medica!
Since 1984, ASA has been taking part in the most important world exhibition for the medical sector, making it a platform for presenting its devices and an opportunity for development toward new markets. With over 120 thousand visitors of which 68% from Europe and 32% from other countries (Asia 59%, America 25%, Africa 14%, and Australia 2%), the fair represents a cornerstone in the internationalization strategies of the company, which, for the 2019 edition (18/21 November, Düsseldorf), makes the innovation-tradition duo its guideline.
“‘Innovation,’ explains Roberto Marchesini, ASA Managing Director, ‘for the technologies that define our therapies. Tradition, instead, for the historical nature of our company, which has always placed the well-being of the person at the centre of its business, focusing on research as the basis of development for increasingly effective, safe, and high-performance therapies.’
The therapeutic solutions will be indeed the true protagonists of the ASA exhibition space (stand 11A19), where people will be able to see the complete range of medical devices – Hilterapia®, MLS® Laser Therapy, and Qs PMT – with a specific focus reserved for ‘HIRO TT’ and ‘MiS’.
"HIRO TT" and "MiS": 2 solutions that change the laser therapy landscape
‘In TT and MiS,’ continues the Managing Director, ‘converge years of research that confirm the value of the therapeutic effects of our laser therapies with efficacy and safety. We have reserved a leading role for them at the stand, because they fully represent our growth and the solidity of our studies’ .
Specifically, MiS is the synthesis of the synchronized action of the MLS® pulse, from which it inherits the wavelengths, the proven efficacy and scientific evidence, and the pulsed power of Hilterapia®.
This makes it the starting point for the development of a new generation of therapeutic devices resulting from the technological and scientific know-how acquired by the company.
HIRO TT, instead, inheriting all the peculiarities of Hilterapia® – first and foremost the quality of emission and clinical efficacy– and incorporating specific application methods, is its natural evolution. Founded on the principle of thermal exchange, synergistically combining the benefits of the SmartCooler refrigeration system and the pulsed Nd:YAG laser source of Hilterapia®, HIRO TT generates a dual and parallel treatment that produces clear and lasting results.
A complete interdisciplinary staff
What gives even more value to ASA’s participation in Medica is the professionalism of the staff at the stand.
‘For several years,’ explains Carlo Marchesini, Market Development Manager, ‘the various company divisions have been represented by specific reference professionals at the complete service of the visitors, customers, and distributors who come to visit us. We are recognized all over the world as manufactures of high-quality devices and this is the result of the work of a team that constantly grows every year and is composed of attentive professionals. Medica represents an opportunity for all our collaborators: in just four days you can “go around the world” and return to the headquarters with a good global overview of the sector in which we operate and with many ideas to share and discuss to grow together.’
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.